OOIR: Observatory of International Research

Papers

(The H4-Index of Allergy is 55. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
In this Issue: Graphical Abstracts	735
Issue Information	359
Issue Information	321
Issue Information	276
In Memory of Dr. Izabela Kuprys‐Lipinska: A Pioneering Clinician, Scientist, and Beloved Friend	228
The Presence and Pathogenic Roles of M(IL‐33 + IL‐2) Macrophages in Allergic Airway Inflammation	178
Correspondence to “Basophil activation test as predictor of severity and threshold of allergic reactions to egg”	170
Type 2 memory B cells: The repository of allergic memory?	161
Vaccine based on folded receptor binding domain‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants	156
The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2	151
Angiomotin and angiostatin as asthma biomarkers: Implications for the regulation of airway remodeling and inflammation	149
Core Outcome Set for IgE‐mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study ‘COMFA’	145
Immunoglobulin E response in health and disease beyond allergic disorders	130
Shotgun metagenomic sequencing on skin microbiome indicates dysbiosis exists prior to the onset of atopic dermatitis	113
	112
Algorithms in allergy: An algorithm for alpha‐Gal syndrome diagnosis and treatment, 2024 update	107
Prospective (e‐diary) vs retrospective (ARIA) measures of severity in allergic rhinoconjunctivitis: An observational compatibility study	107
Impact of COVID‐19 on care‐seeking patterns for hay fever in Japan: A retrospective claims database cohort study	105
Longitudinal analyses of development of the immune system during the first five years of life in relation to lifestyle	104
Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis”	96
Clinical applicability of the urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes	96
Next generation health guidelines: The role of real‐life data in evidence‐based medicine	95
25‐hydroxyvitamin D and risk of atopic diseases and infections in early childhood	93
One‐strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable	88
In memoriam: Lawrence M. Lichtenstein (1934–2022)	88

MUC1 deficiency induces the nasal epithelial barrier dysfunction via RBFOX3 shortage augment ubiquitin–proteasomal degradation in allergic rhinitis pathogenesis	84
Efficacy and safety of intranasal medications for allergic rhinitis: Network meta‐analysis	83
Persistence of infectious SARS‐CoV‐2 particles for up to 37 days in patients with mild COVID‐19	80
Pre‐existing inflammation reduces the response to contact allergens in Tmem79‐deficient mice	79
In vivo and ex vivo inflammatory responses of the esophageal mucosa to food challenge in adults with eosinophilic esophagitis	77
Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures	76
Long‐term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open‐label extension study	75
Intranasal administration of a virus like particles‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern	72
An algorithm for the diagnosis and management of IgE‐mediated food allergy, 2024 update	71
Impact of climate change on atopic dermatitis: A review by the International Eczema Council	70
Prevention of infant eczema by neonatal Bacillus Calmette‐Guérin vaccination: The MIS BAIR randomized controlled trial	69
Airway epithelial cell cilia transcriptomic dysregulation is associated with the inflammatory phenotype in asthma	67
Development and validation of the food allergy severity score	67
Hot topics in allergen immunotherapy, 2023: Current status and future perspective	67
The impact of exposure to tobacco smoke and e‐cigarettes on asthma‐related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma	66
Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies	66
IgG Removal Enhances the Sensitivity of Amoxicillin‐Specific IgE Detection in ImmunoCAP and Radioallergosorbent Test	65
Oral and Gut Microbial Hubs Associated With Reaction Threshold Interact With Circulating Immune Factors in Peanut Allergy	64
The Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3⁺ Tregs	63
Issue Information ‐ TOC	63
Preclinical Development of GR2002, a Novel Anti‐TSLP Bispecific Antibody With Potent TSLP Inhibitory Effects	63
TOP10‐SCAR: A Global Pharmacovigilance Study on Medications Most Frequently Related to Severe Cutaneous Adverse Reactions	63
In this Issue: Graphical Abstracts	62
Issue Information	61
Issue Information	59
What we know and still ignore on COVID‐19 immune pathogenesis and a proposal based on the experience of allergic disorders	58
Evidence of epithelial remodelling but not epithelial–mesenchymal transition by transcriptome profiling in vernal keratoconjunctivitis	58
Mast cell activation is associated with post‐acute COVID‐19 syndrome	57
Sputum transcriptome analysis of co‐regulated genes related to arachidonic acid metabolism in N‐ERD	56
	55
Type 2 IgG Memory B Cells as Precursors of IgE Plasma Cells	55
Severe and refractory anaphylaxis in pediatric intensive care unit	55